The collaboration aims to enhance global clinical research, promote AI-integrated medical solutions, and increase access to compliance wellness products in India, the US and Africa, the company said in a statement.
“This strategic partnership with SFRI reflects our commitment to driving global standards in clinical research and healthcare innovation by leveraging our strengths in regulatory science, AI-driven testing and product development,” said Saurabh Arora, Research Managing Director.
SFRI will also support regulatory strategies, public health cooperation and commercial partnerships in markets such as Nigeria and the US, the statement said.
This includes the possibility of product registration with national health organizations, connecting Auriga with distributors and marketers to directly support sales outreach and supply chain strategies.
“This partnership presents the strengths of AURIGA's clinical research expertise and AI and regulatory capabilities to accelerate the development of compliant, patient-centric health innovations, strategic steps to fill global regulatory ecosystems, and strategic steps to scale evidence-based wellness solutions across the region by managing regulations, and more,” said SFRI CEO John Ademora. The two organizations will jointly expand their research training programs through both digital platforms and face-to-face sessions, while co-developing AI applications for healthcare.
Additionally, both organizations will pursue government and foundation-funded projects to promote impact on the global healthcare system.
